
‘Coping With Cancer in Early Adulthood’ addresses issues of patients 18 to 49 years old.

‘Coping With Cancer in Early Adulthood’ addresses issues of patients 18 to 49 years old.

CURE attended the Hairy Cell Leukemia Foundation 2025 Conference where medical experts gathered to discuss advances in research and patient care.

As Liver Cancer Awareness Month ends, Drs. Vogel and Yarchoan highlight the urgent need for greater awareness, support and resources for liver cancer.

CURE spoke with Dr. Rosario Ligestri and Dr. Anna Berkenblit about the rising rate of pancreatic cancer in relatively younger adults.

Dr. Dima El-Sharkawi discusses how hairy cell leukemia typically presents in patients and the challenges clinicians face in identifying the disease early.

For Silvia Davis, a breast cancer diagnosis at the age of 36 led to a fertility preservation journey that resulted in her son, John.

Dr. Anjana Pillai says treatment depends on stage and health, with surgery, transplant, local therapy or systemic drugs to help people live longer.

Emerging investigational agents may shift the current standard of care for patients with the rare sarcoma known as gastrointestinal stromal tumor (GIST).

Chester Freeman shares how the Japanese philosophy of wabi-sabi helped him embrace his scar and find beauty in imperfection while living with leukemia.

Three experts in breast surgery, medical oncology and reconstructive surgery share their insights on the importance of Breast Cancer Awareness Month.

Scalp cooling helped Maureen Green feel more like herself during chemotherapy, giving her control over her appearance at a time filled with fear and uncertainty.

During Liver Cancer Awareness Month, Dr. Anjana Pillai says more treatment options, growing trials and ongoing research offer hope for patients.

CURE contributor Ronald D. Chin received a diagnosis of multiple myeloma in 2017 and has been in remission since 2023.

The FDA has approved Blenrep with BVd as a third-line treatment for relapsed or refractory multiple myeloma.

Dr. Sheldon M. Feldman says patients with breast cancer should accept support and make exercise and wellness priorities during treatment to improve outcomes.

CURE spoke with Alyson B. Moadel-Robblee of Montefiore Einstein Center for Cancer Care.

CURE spoke with Alexa M. Lantz of Penn State Health about radiation side effects.

Reiki master Twanda Frazier says reiki helps patients with cancer release what no longer serves them and restore emotional and spiritual balance.

CURE spoke with Dr. Surbhi Sidana about the recently approved antibody-drug conjugate Blenrep for multiple myeloma.

Dr. Alessandro Gozzetti highlights fertility and reproductive health as often overlooked but vital aspects of survivorship in hairy cell leukemia.

Combining Rituxan with Mavenclad or Zelboraf upfront can extend remissions safely and should become standard first-line therapy for hairy cell leukemia.

CURE sat down with Dr. Kerry A. Rogers for an interview at the Hairy Cell Leukemia Foundation 2025 Conference, hosted in Bologna, Italy.

The MELODY study found music therapy to be effective at relieving the anxiety of cancer survivors.

After being diagnosed with stage 3 triple-negative breast cancer at 29, Meagan Pettit urges young adults to seek community and define life beyond diagnosis.

Experts discuss how better hospice and home care reimbursement can help patients receive compassionate end-of-life care at home.

Breast cancer survivors highlighted guidance and encouragement they received when first diagnosed, offering reassurance for those who are newly diagnosed.

Stephanie Wachtel told CURE that areola tattooing after HER2-positive breast cancer helped her feel whole again and reconnect with her creativity.

Dr. Anjana Pillai explains that staging liver cancer involves assessing tumor size, spread, and vessel involvement to guide treatment.

When reflecting on the Japanese art of kintsugi, one can find inspiration during a cancer journey, as CURE columnist Chester Freeman explained.

A study found exercise after treatment boosts cancer survival, prompting experts to call for structured movement as a standard part of survivorship care.